title: Resilience to meet the challenge of addiction: psychobiology and clinical considerations.
abstract: Acute and chronic stress-related mechanisms play an important role in the development of addiction and its chronic, relapsing nature. Multisystem adaptations in brain, body, behavioral, and social function may contribute to a dysregulated physiological state that is maintained beyond the homeostatic range. In addition, chronic abuse of substances leads to an altered set point across multiple systems. Resilience can be defined as the absence of psychopathology despite exposure to high stress and reflects a person's ability to cope successfully in the face of adversity, demonstrating adaptive psychological and physiological stress responses. The study of resilience can be approached by examining interindividual stress responsibility at multiple phenotypic levels, ranging from psychological differences in the way people cope with stress to differences in neurochemical or neural circuitry function. The ultimate goal of such research is the development of strategies and interventions to enhance resilience and coping in the face of stress and prevent the onset of addiction problems or relapse.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, Howard University, Washington, DC, USA.
authors.forename: Tanja N
authors.initials: TN
authors.lastname: Alim
authors.forename: William B
authors.initials: WB
authors.lastname: Lawson
authors.forename: Adriana
authors.initials: A
authors.lastname: Feder
authors.forename: Brian M
authors.initials: BM
authors.lastname: Iacoviello
authors.forename: Shireen
authors.initials: S
authors.lastname: Saxena
authors.forename: Christopher R
authors.initials: CR
authors.lastname: Bailey
authors.forename: Allison M
authors.initials: AM
authors.lastname: Greene
authors.forename: Alexander
authors.initials: A
authors.lastname: Neumeister
mesh_terms: D000223:Adaptation, Psychological / Q000502:physiology*; D004298:Dopamine / Q000502:physiology; D063388:Endocannabinoids / Q000502:physiology; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology; D009478:Neuropeptide Y / Q000502:physiology; D009638:Norepinephrine / Q000502:physiology; D010913:Pituitary-Adrenal System / Q000502:physiology; D055500:Resilience, Psychological; D012701:Serotonin / Q000502:physiology; D013315:Stress, Psychological / Q000523:psychology*; D019966:Substance-Related Disorders / Q000523:psychology*
chemical_list: D063388:Endocannabinoids; D009478:Neuropeptide Y; D012701:Serotonin; D004298:Dopamine; D009638:Norepinephrine